ANTIHYPERTENSIVE THERAPY AND LIPIDS - EVIDENCE, MECHANISMS, AND IMPLICATIONS

被引:196
作者
WEINBERGER, MH
机构
关键词
D O I
10.1001/archinte.145.6.1102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1102 / 1105
页数:4
相关论文
共 54 条
[1]   ELEVATION OF SERUM-LIPID LEVELS DURING DIURETIC THERAPY OF HYPERTENSION [J].
AMES, RP ;
HILL, P .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) :748-757
[2]  
AMES RP, 1982, J CARDIOVASC PHARM, V4, pS206
[3]   METABOLIC DISTURBANCES INCREASING THE RISK OF CORONARY HEART-DISEASE DURING DIURETIC-BASED ANTIHYPERTENSIVE THERAPY - LIPID ALTERATIONS AND GLUCOSE-INTOLERANCE [J].
AMES, RP .
AMERICAN HEART JOURNAL, 1983, 106 (05) :1207-1214
[4]  
[Anonymous], 1978, J Chronic Dis, V31, P201
[5]  
[Anonymous], 1979, JAMA, V242, P2562
[6]  
[Anonymous], 1982, JAMA, V248, P1465
[7]  
BRELMAN P, 1979, INT J CLIN PHARM THE, V17, P378
[8]  
BROWN MS, 1981, SCIENCE, V212, P623
[9]   EPIDEMIOLOGY OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A) :4-12
[10]   METABOLIC CONSEQUENCES OF ATENOLOL AND PROPRANOLOL IN TREATMENT OF ESSENTIAL HYPERTENSION [J].
DAY, JL ;
SIMPSON, N ;
METCALFE, J ;
PAGE, RL .
BRITISH MEDICAL JOURNAL, 1979, 1 (6156) :77-80